Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India

Imatinib inhibits constitutively active BCR-ABL tyrosine kinase of chronic myeloid leukemia (CML). In a long term study it was found superior to interferon alfa plus cytarabine for newly diagnosed CML in the chronic phase. However, till date there is no major study to evaluate eastern Indian CML pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mukhopadhyay, A., Dasgupta, S., Mukhopadhyay, S., Bose, C. K., Sarkar, S., Gharami, F., Koner, S., Basak, J., Roy, U. K.
Formato: Artigo
Idioma:Inglês
Publicado: Springer-Verlag 2011
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3332275/
https://ncbi.nlm.nih.gov/pubmed/23730014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-011-0108-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares